Semnur Pharmaceuticals, Inc. Investing Cash Flow
Semnur Pharmaceuticals, Inc. (SMNR) reported Investing Cash Flow of $8.62 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-15.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2025-08-15
- Semnur Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Semnur Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2023-12-31 was $40.54M.
- Semnur Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2023-09-30 was $0.00.
- Semnur Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2022-12-31 was $0.00.
- Semnur Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2024 was $43.43M, a 9.35% increase from fiscal 2023.
- Semnur Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2023 was $39.71M.
- Semnur Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$84.15M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2025-06-30 | $8.62M 10-Q · filed 2025-08-15 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-02 | $43.43M 10-K · filed 2025-04-02 | ||
| 2024-09-30 | $43.43M 10-Q · filed 2024-11-19 | |||
| 2023-12-31 | $40.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-02 | $40.54M derived: sum of 2 quarters · filed 2025-04-02 | $39.71M 10-K · filed 2025-04-02 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | -$825.00K 10-Q · filed 2024-11-19 | ||
| 2023-06-30 | -$825.00K 10-Q · filed 2024-08-19 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | -$84.15M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$84.15M 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | -$84.15M 10-Q · filed 2023-08-15 |